Meghan Swardstrom

VP of Clinical Development & Operations

Meghan joined Impel NeuroPharma as Vice President of Clinical Development & Operations in late 2017. Drawing on over 20 years’ experience in Clinical Research and Operations roles of increasing responsibilities, Meghan’s emphasis is building clinical teams and sustainable infrastructure. Prior to joining Impel, Meghan was Principal for Emerald Clinical Consulting, providing clinical development and operations strategy and support to several small biotech companies.

Meghan-Swardstrom